Diagnostic difficulties in pernicious anemia.
Oo TH.
Discov Med. 2019 Nov-Dec;28(155):247-253.
VEXAS syndrome: An update.
Khitri MY, Hadjadj J, Mekinian A, Jachiet V.
Joint Bone Spine. 2024 Jul;91(4):105700. doi: 10.1016/j.jbspin.2024.105700. Epub 2024 Feb 1.
MDS overlap disorders and diagnostic boundaries.
Tanaka TN, Bejar R.
Blood. 2019 Mar 7;133(10):1086-1095. doi: 10.1182/blood-2018-10-844670. Epub 2019 Jan 22.
Schimke Immunoosseous Dysplasia.
Lippner E, Lücke T, Salgado C, Boerkoel C, Lewis DB.
2002 Oct 1 [updated 2023 Mar 30]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
Juvenile myelomonocytic leukemia.
Proytcheva M.
Semin Diagn Pathol. 2011 Nov;28(4):298-303. doi: 10.1053/j.semdp.2011.08.007.
Bupropion-induced pancytopenia.
Kim JL, Chercover D, Masoudi H, Foltz L.
BMJ Case Rep. 2024 Nov 26;17(11):e262831. doi: 10.1136/bcr-2024-262831.
[VEXAS Syndrome].
Jachiet V, Comont T, Kosmider O, Zhao LP, Mekinian A, Fain O, Hadjadj J.
Rev Prat. 2025 Feb;75(2):196-200.
Anemia as the Main Manifestation of Myelodysplastic Syndromes.
Santini V.
Semin Hematol. 2015 Oct;52(4):348-56. doi: 10.1053/j.seminhematol.2015.06.002. Epub 2015 Jun 30.
Iron overload induces dysplastic erythropoiesis and features of myelodysplasia in Nrf2-deficient mice.
Duarte TL, Lopes M, Oliveira M, Santos AG, Vasco C, Reis JP, Antunes AR, Gonçalves A, Chacim S, Oliveira C, Porto B, Teles MJ, Moreira AC, Silva AMN, Schwessinger R, Drakesmith H, Henrique R, Porto G, Duarte D.
Leukemia. 2024 Jan;38(1):96-108. doi: 10.1038/s41375-023-02067-9. Epub 2023 Oct 19.
Thiamine-Responsive Megaloblastic Anemia Syndrome Mimicking Myelodysplastic Neoplasm.
Klötzer C, Schnabel F, Kubasch AS, Jentzsch M, Franke GN, Uhlig J, Faust H, Jauss RT, Oppermann H, Popp D, Metzeler KH, Lemke JR, Vučinić V, Platzbecker U.
Acta Haematol. 2024 Oct 28:1-5. doi: 10.1159/000542286. Online ahead of print.
